CYP24A1 and pseudotumor cerebri: In 2011, Schlingmann et al (18) were the first researchers who defined loss-of-function mutations in the cytochrome P450 24A1 gene (CYP24A1), which encodes vitamin D hydroxylase in patients with IIH.